US
Updated
Reviewed by Chandani Patel
US Meal Replacement Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $6.75 Bn.
Canada at 6.2% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.94 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $6.48 Bn | — | — |
| 2025 (base) | $6.75 Bn | +$265.7 Mn | — |
| 2026 (forecast) | $7.02 Bn | +$276.6 Mn | +4.1% |
| 2027 (forecast) | $7.31 Bn | +$288.0 Mn | +8.4% |
| 2028 (forecast) | $7.61 Bn | +$299.8 Mn | +12.8% |
| 2029 (forecast) | $7.92 Bn | +$312.1 Mn | +17.4% |
| 2030 (forecast) | $8.25 Bn | +$324.9 Mn | +22.3% |
| 2031 (forecast) | $8.59 Bn | +$338.2 Mn | +27.3% |
| 2032 (forecast) | $8.94 Bn | +$352.1 Mn | +32.5% |
| 2033 (forecast) | $9.31 Bn | +$366.5 Mn | +37.9% |
| 2034 (forecast) | $9.69 Bn | +$381.5 Mn | +43.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$6.75 Bn
Canada
$1.30 Bn
China
$1.06 Bn
Japan
$995.1 Mn
Germany
$570.4 Mn
France
$445.2 Mn
Italy
$362.6 Mn
Brazil
$363.6 Mn
UK
$331.5 Mn
Ecuador
$297.7 Mn
Spain
$258.4 Mn
India
$272.4 Mn
Saudi Arabia
$246.6 Mn
Mexico
$213.3 Mn
Australia
$187.9 Mn
New Zealand
$162.4 Mn
Russia
$151.6 Mn
South Africa
$106.0 Mn
UAE
$66.4 Mn
Egypt
$44.0 Mn
Philippines
$36.6 Mn
Malaysia
$25.6 Mn
Hong Kong
$25.0 Mn
Thailand
$18.1 Mn
Singapore
$16.5 Mn
Kenya
$10.6 Mn
| Market size, 2025 | $6.75 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $9.69 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, use and distribution channel (see all) |
| Key players | Herbalife Nutrition, Abbott Laboratories, Nestle, Glanbia PLC, Huel and 1 more (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026.Source: US Food and Drug Administration. Checked 14 Nov 2026. |
| Active clinical trials | 17 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Meal replacement products are shakes, bars and powders that replace a meal with set calories and nutrients, often used for weight control.
Key segments of the meal Replacement Products market include product (Shakes and Drinks, Powders and Bars) and use (Weight Management, Medical Nutrition and Busy Lifestyles).
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the meal Replacement Products market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the meal Replacement Products market, especially in fast-growing emerging economies.
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the meal Replacement Products market. Long-term safety data and lifestyle support are still needed for many patients.
The meal Replacement Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.[1] Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products.[2] ClinicalTrials.gov lists 17 studies on Meal Replacement Products that are recruiting, active or about to start in the US.[3] Obesity (adults): 41.0% of adults in 2024, the latest WHO figure for the US.[4]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
[4] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern meal Replacement Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in Meal Replacement Products right now, from free public sources.
17 active trials in the US
Recruiting, about to start, or running now.
41.0 % of adults
Obesity (adults), US, 2024 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Pharmaceuticals · US
Medical Devices · US
Medical Devices · US
Medical Devices · US
Pharmaceuticals · US
Pharmaceuticals · US
